Alzheimer's disease 老年痴呆症
reviewarticle
48.49.50.
Murai,K.K.etal.Controlofhippocampaldendriticspinemorphologythroughephrin-A3/EphA4signaling.NatureNeurosci.6,153–160(2003).
Cummings,B.J.etal.NeuriticinvolvementwithinbFGFimmunopositiveplaquesofAlzheimer’sdisease.Exp.Neurol.124,315–325(1993).
Barger,S.W.etal.Tumornecrosisfactorsalphaandbetaprotectneuronsagainstamyloidbeta-peptidetoxicity:evidenceforinvolvementofakappaB-bindingfactorandattenuationofperoxideandCa2þaccumulation.Proc.NatlAcad.Sci.USA92,9328–9332(1995).
Pope,S.K.,Shue,V.M.&Beck,C.WillahealthylifestylehelppreventAlzheimer’sdisease?Annu.Rev.PublicHealth24,111–132(2003).
Zandi,P.P.etal.ReducedriskofAlzheimerdiseaseinusersofantioxidantvitaminsupplements:theCacheCountyStudy.Arch.Neurol.61,82–88(2004).
Wang,H.X.etal.VitaminB(12)andfolateinrelationtothedevelopmentofAlzheimer’sdisease.Neurology56,1188–1194(2001).
Dewachter,L.&VanLeuven,F.SecretasesastargetsforthetreatmentofAlzheimer’sdisease:theprospects.LancetNeurol.1,409–416(2002).
John,V.etal.Humanbeta-secretase(BACE)andBACEinhibitors.J.Med.Chem.46,4625–4630(2003).
Roberds,S.L.etal.BACEknockoutmicearehealthydespitelackingtheprimarybeta-secretaseactivityinbrain:implicationsforAlzheimer’sdiseasetherapeutics.Hum.Mol.Genet.10,1317–1324(2001).
Ritchie,C.W.etal.Metal-proteinattenuationwithiodochlorhydroxyquin(clioquinol)targetingAbetaamyloiddepositionandtoxicityinAlzheimerdisease:apilotphase2clinicaltrial.Arch.Neurol.60,1685–1691(2003).
Schenk,D.etal.Immunizationwithamyloid-betaattenuatesAlzheimer-disease-likepathologyinthePDAPPmouse.Nature400,173–177(1999).
McLaurin,J.etal.Therapeuticallyeffectiveantibodiesagainstamyloid-betapeptidetargetamyloid-betaresidues4–10andinhibitcytotoxicityand brillogenesis.NatureMed.8,1263–1269(2002).Kotilinek,L.A.etal.ReversiblememorylossinamousetransgenicmodelofAlzheimer’sdisease.J.Neurosci.22,6331–6335(2002).
Hock,C.etal.Antibodiesagainstbeta-amyloidslowcognitivedeclineinAlzheimer’sdisease.Neuron38,547–554(2003).
Hoozemans,J.J.etal.Non-steroidalanti-in ammatorydrugsandcyclooxygenaseinAlzheimer’sdisease.Curr.DrugTargets4,461–468(2003).
Resnick,S.M.&Henderson,V.W.HormonetherapyandriskofAlzheimerdisease.J.Am.Med.Assoc.288,2170–2172(2002).
Buxbaum,J.D.etal.Evidencethattumornecrosisfactoralphaconvertingenzymeisinvolvedinregulatedalpha-secretasecleavageoftheAlzheimeramyloidproteinprecursor.J.Biol.Chem.273,27765–27767(1998).
Asai,M.etal.PutativefunctionofADAM9,ADAM10,andADAM17asAPPalpha-secretase.Biochem.Biophys.Res.Commun.301,231–235(2003).
Leissring,M.A.etal.Aphysiologicsignalingroleforthegamma-secretase-derivedintracellularfragmentofAPP.Proc.NatlAcad.Sci.USA99,4697–4702(2002).
Lu,D.C.etal.Asecondcytotoxicproteolyticpeptidederivedfromamyloidbeta-proteinprecursor.NatureMed.6,397–404(2000).
Yu,G.etal.Nicastrinmodulatespresenilin-mediatednotch/glp-1signaltransductionandbetaAPPprocessing.Nature407,48–54(2000).
Francis,R.etal.aph-1andpen-2arerequiredforNotchpathwaysignaling,gamma-secretasecleavageofbetaAPP,andpresenilinproteinaccumulation.Dev.Cell3,85–97(2002).
Takasugi,N.etal.Theroleofpresenilincofactorsinthegamma-secretasecomplex.Nature422,438–441(2003).
Shen,J.etal.SkeletalandCNSdefectsinPresenilin-1-de cientmice.Cell89,629–639(1997).Lazarov,O.,Lee,M.,Peterson,D.A.&Sisodia,S.S.Evidencethatsynapticallyreleasedbeta-amyloidaccumulatesasextracellulardepositsinthehippocampusoftransgenicmice.J.Neurosci.22,9785–9793(2002).
Kimberly,W.T.etal.Theintracellulardomainofthebeta-amyloidprecursorproteinisstabilizedbyFe65andtranslocatestothenucleusinanotch-likemanner.J.Biol.Chem.276,40288–40292(2001).Yankner,B.A.etal.Neurotrophicandneurotoxiceffectsofamyloidbetaprotein:reversalbytachykininneuropeptides.Science250,279–282(1990).
Lambert,M.P.etal.Diffusible,non brillarligandsderivedfromAbeta1–42arepotentcentralnervoussystemneurotoxins.Proc.NatlAcad.Sci.USA95,6448–6453(1998).
Kayed,R.etal.Commonstructureofsolubleamyloidoligomersimpliescommonmechanismofpathogenesis.Science300,486–489(2003).
77.Chapman,P.F.etal.Impairedsynapticplasticityandlearninginagedamyloidprecursorprotein
transgenicmice.NatureNeurosci.2,271–276(1999).
78.Koistinaho,M.etal.Speci cspatiallearningde citsbecomeseverewithageinbeta-amyloid
precursorproteintransgenicmicethatharbordiffusebeta-amyloiddepositsbutdonotformplaques.Proc.NatlAcad.Sci.USA98,14675–14680(2001).
79.Kamenetz,F.etal.APPprocessingandsynapticfunction.Neuron37,925–937(2003).
80.Gong,Y.etal.Alzheimer’sdisease-affectedbrain:presenceofoligomericAbetaligands(ADDLs)
suggestsamolecularbasisforreversiblememoryloss.Proc.NatlAcad.Sci.USA100,10417–10422(2003).
81.Klein,W.L.,Krafft,G.A.&Finch,C.E.TargetingsmallAboligomers:thesolutiontoan
Alzheimer’sdiseaseconundrum?TrendsNeurosci.24,219–224(2001).
82.Oster-Granite,M.L.etal.Age-dependentneuronalandsynapticdegenerationinmicetransgenic
fortheCterminusoftheamyloidprecursorprotein.J.Neurosci.16,6732–6741(1996).
83.Oddo,S.etal.Triple-transgenicmodelofAlzheimer’sdiseasewithplaquesandtangles:intracellular
Abetaandsynapticdysfunction.Neuron39,409–421(2003).
84.Mucke,L.etal.High-levelneuronalexpressionofabeta1–42inwild-typehumanamyloidprotein
precursortransgenicmice:synaptotoxicitywithoutplaqueformation.J.Neurosci.20,4050–4058(2000).
85.Chan,S.L.,Furukawa,K.&Mattson,M.P.PresenilinsAPPinneuriticandsynapticplasticity:
implicationsforthepathogenesisofAlzheimer’sdisease.NeuromolecularMed.2,167–196(2002).86.Stahl,R.etal.AssessmentofaxonaldegenerationonAlzheimer’sdiseasewithdiffusiontensorMRI.
Radiologe43,566–575(2003).
87.Buxbaum,J.D.etal.Alzheimeramyloidproteinprecursorintherathippocampus:transportand
processingthroughtheperforantpath.J.Neurosci.18,9629–9637(1998).
88.Mandelkow,E.M.etal.Cloggingofaxonsbytau,inhibitionofaxonaltraf candstarvationof
synapses.Neurobiol.Aging24,1079–1085(2003).
89.Lee,V.M.,Goedert,M.&Trojanowski,J.Q.Neurodegenerativetauopathies.Annu.Rev.Neurosci.
24,1121–1159(2001).
90.Masliah,E.etal.Alteredexpressionofsynapticproteinsoccursearlyduringprogressionof
Alzheimer’sdisease.Neurology56,127–129(2001).
91.Yao,P.J.Synapticfrailtyandclathrin-mediatedsynapticvesicletraf ckinginAlzheimer’sdisease.
TrendsNeurosci.27,24–29(2004).
92.Yuan,J.&Yankner,B.A.Apoptosisinthenervoussystem.Nature407,802–809(2000).
93.Mattson,M.P.Apoptosisinneurodegenerativedisorders.NatureRev.Mol.CellBiol.1,120–129
(2000).
94.Eckert,A.etal.Mitochondrialdysfunction,apoptoticcelldeath,andAlzheimer’sdisease.Biochem.
Pharmacol.66,1627–1634(2003).
95.McPhie,D.L.etal.DNAsynthesisandneuronalapoptosiscausedbyfamilialAlzheimerdisease
mutantsoftheamyloidprecursorproteinaremediatedbythep21activatedkinasePAK3.J.Neurosci.23,6914–6927(2003).
96.Lee,M.S.etal.Neurotoxicityinducescleavageofp35top25bycalpain.Nature405,360–364
(2000).
97.Kruman,I.I.etal.CellcycleactivationlinkedtoneuronalcelldeathinitiatedbyDNAdamage.
Neuron41,549–561(2004).
98.VanLeeuwen,F.W.etal.Frameshiftmutantsofbetaamyloidprecursorproteinandubiquitin-Bin
Alzheimer’sandDownpatients.Science279,242–247(1998).
99.Song,S.etal.EssentialroleofE2–25K/Hip-2inmediatingamyloid-betaneurotoxicity.Mol.Cell12,
553–563(2003).
100.Pedersen,W.A.,Wan,R.,Zhang,P.&Mattson,M.P.Urocortin,butnoturocortinII,protects
culturedhippocampalneuronsfromoxidativeandexcitotoxiccelldeathviacorticotropin-releasinghormonereceptortypeI.J.Neurosci.22,404–412(2002).76.
51.52.53.54.55.56.
57.
58.59.60.61.62.63.64.
65.66.67.68.69.70.71.72.
73.74.75.
CompetinginterestsstatementTheauthordeclaresthathehasnocompeting nancialinterests.CorrespondenceandrequestsformaterialsshouldbeaddressedtoM.P.M.(mattsonm@grc.nia.nih.gov).
NATURE|VOL430|5AUGUST2004|doc.guandang.net
©2004Nature PublishingGroup
639
Mattson review-alzheim... 9页 1下载券 Iron-Export Ferroxidas... 11页 ...网址(参阅以上附加链接)阿尔茨海默氏病国际 (Alzheimer's Disease International)...
Regimen Summary of Peptide Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD...
ALZHEIMER’S DISEASE 41页 1下载券 喜欢此文档的还喜欢 2010-Alzheimer's-... Mattson review-alzheim... 9页 1下载券 Alzheimer’s disease s... 12页...
Therapy_of_Alzheimer's... 19页 免费 Mattson review-alzheim... 9页 1...(2010) 158–194 Alzheimer’s Association Report 2010 Alzheimer’s disease ...
健康讲座--老年痴呆_医药卫生_专业资料。老年痴呆症,又称阿尔茨海默病(Alzheimer'sdisease,AD)是发生在老年期及老年前期的一种原发性退行性脑病,指的是一种持续...
其中,阿尔茨海默病 (Alzheimer's disease,AD),是一种最常见的、主要的老年痴呆症 ,它是一种进行 性发展的致死性神经退行性疾病,临床表现为认知和记忆功能不断...
Alzheimer's Disease Summ... 14页 20财富值 Therapy_of_Alzheimer's_D....AT ALL LEVELS (Ashford, Mattson, Kumar, 1998; Teter, Ashford, 2002) ? ...
? ? ? ? Spelling (30s) 老年痴呆症 Alzheimer...The memory curve: review and try to use the ...Alzheimer’s disease: condition in which a ...
什么是老年痴呆所谓的老年痴呆症,又称阿尔茨海默病 (Alzheimer's disease,AD) 是发 生在老年期及老年前期的一种原发性退行性脑病, 指的是一种持续性高级神经功...
1 病因病机 老年痴呆症主要包括阿尔茨海默病 (Alzheimer’ s disease , AD) 和血管性痴呆(Vascular Dementia,VD)、混合性痴呆、其他痴呆(外伤、帕金森)。AD 和 ...
热门文档